| Literature DB >> 23031584 |
Satheesh Kumar Dharmarajan1, Kottai Muthu Arumugam.
Abstract
The objective of the study is a comparative evaluation of flavone isolated from Mucuna pruriens and coumarin isolated from Ionidium suffruticosum was assessed for the hypolipidemic activity in rats fed with high fat diet. The acute toxicity study was found that flavone (M.pruriens) and coumarin (I.suffruticosum) are safe up to 100 mg/kg, so one tenth of this dose (10 mg/kg) was consider as a evaluation dose. High fat diet group of rats showed significant (p<0.001) elevation in plasma total and LDL-cholesterol, triglycerides and phospholipids. Administration of flavone (M. pruriens) and coumarin isolated from (I.suffruticosum) at the dose of 10mg/kg b.wt/day along with high fat diet significantly (p<0.001) prevented the rise in the plasma total and LDL-cholesterol, triglycerides and phospholipids than that of other extracts. However, treatment of coumarin isolated from (I.suffruticosum) had showed more cardio protective effect against hyperlipidemia than that of flavone (M.pruriens).Entities:
Mesh:
Substances:
Year: 2012 PMID: 23031584 PMCID: PMC3506435 DOI: 10.1186/1476-511X-11-126
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Average Body weight changes in control and experimental rats
| Group I | 137.34±0.47bNS | 156.66±2.47b* | 19.32±2.39b* |
| Group II | 136.33±0.42aNS | 198.64±2.58a* | 62.31±1.90a* |
| Group III | 136.71±0.41aNS,bNS | 162.33±2.16aNS,b** | 25.62±2.54aNS, b* |
| Group IV | 136.57±0.53aNS,bNS | 161.26±1.38aNS,b* | 24.69±3.28aNS,b* |
| Group V | 137.55±0.74aNS,bNS | 161.51±1.74aNS,b* | 23.96±3.39 aNS,b* |
Values are expressed as mean ± SE (n=6 rats); P values: *<0.001, **<0.05; NS: Non significant; a → group I compared with groups II, III, IV& V; b → group II compared with groups III, IV& V; Group I : Standard chow diet (Control); Group II : High Fat Diet (Negative Control); Group III : HFD + Flavone (M.pruriens) (10mg/kg b.wt); Group IV : HFD+Coumarin (I. suffruticosum) (10mg/kg b.wt); Group V : HFD + Atorvastatin (1.2 mg/kg b.wt) (Positive Control).
Effect of flavone from and coumarin from on plasma lipid profile in control and experimental rats
| Group I | 69.81±0.51b* | 23.67±0.43b* | 46.14±0.61b* | 155.87±0.24b* | 78.57 ±0.20b* | 2.90±0.08b* |
| Group II | 167.17±0.26a* | 49.41±0.12a* | 117.76±0.57a* | 208.33±0.33a* | 121.83±0.33a* | 9.73±0.21a* |
| Group III | 77.43 ±0.29a*,b* | 24.36±0.74a*,b* | 53.07±0.82a*,b* | 160.71±0.34a*,b* | 84.03±0.40a*,b* | 3.35±0.18a*,b* |
| Group IV | 72.74±0.47a*,b* | 23.05±0.40a*,b* | 49.69±0.22a*,b* | 156.47±0.12a*,b* | 79.47±0.37a*,b* | 2.88±0.84a*,b* |
| Group V | 72.92 ±0.22a*,b* | 23.44±0.55a*,b* | 49.48±0.56 a*,b* | 156.29±0.28a*,b* | 80.19 ±0.07a*,b* | 2.97±0.53a*,b* |
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non Significant; a →group I compared with groups II, III, IV, V; b →group II compared with groups III, IV, V; Details of group I-V are same as in Table 1.
Effect of flavone from and coumarin from on tissues ester cholesterol profile in control and experimental rats
| Group I | 0.67 ± 0.02b* | 2.86± 0.01b* | 2.02±0.42b* |
| Group II | 2.55±0.04a* | 6.96±0.02a* | 6.81±0.23a* |
| Group III | 2.02±0.01a*,b** | 3.78±0.03a*,b* | 4.98±0.24a*,b* |
| Group IV | 2.59±0.03 a*,b* | 3.10±0.01a*,b* | 2.69±0.09a*,b* |
| Group V | 1.84±0.01a*,b* | 2.98±0.01a*,b* | 2.83±0.11a*,b* |
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non Significant; a →group I compared with groups II, III, IV, V; b →group II compared with groups III, IV, V; Details of group I-V are same as in Table 1.
Effect of flavone from and coumarin from on tissues free cholesterol profile in control and experimental rats
| Group I | 0.65±0.01b* | 0.69± 0.01b* | 0.40±0.01b* |
| Group II | 1.24±0.01a** | 1.17±0.03 a* | 1.86±0.02a* |
| Group III | 0.89 ±0.01a*,b** | 0.12±0.01a**,b* | 0.73±0.01a*,b* |
| Group IV | 0.73±0.01a*,b* | 0.66±0.01a*,b* | 0.62±0.01a*,b* |
| Group V | 0.81±0.04a*,b* | 0.64±0.04a*,b* | 0.63±0.04a*,b* |
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non Significant; a →group I compared with groups II, III, IV, V; b →group II compared with groups III, IV, V; Details of group I-V are same as in Table 1.
Effect of flavone from and coumarin from on tissues Triglyceride level in control and experimental rats
| Group I | 7.95±0.01b* | 9.17±0.01b* | 9.48±0.33b* |
| Group II | 18.11±0.19a* | 28.79±0.16a* | 19.37±0.78a* |
| Group III | 9.57±0.15a*, b* | 16.78± 0.21a**,b* | 12.67±0.11a*,b* |
| Group IV | 8.24±0.10a*,b* | 15.47 ± 0.12a*,b* | 12.08 ± 0.12a*,b* |
| Group V | 8.31±0.69a*,b* | 15.21±0.36a*,b* | 12.15 ± 0.01a*,b* |
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non Significant; a →group I compared with groups II, III, IV, V; b →group II compared with groups III, IV, V; Details of group I-V are same as in Table 1.
Effect of flavone from and coumarin from on tissues Phospholipids level in control and experimental rats
| Group I | 12.37±0.45b* | 18.04 ±0.67b* | 10.32±0.05b* |
| Group II | 25.14±0.69a* | 26.47±0.10a* | 17.45± 0.29a* |
| Group III | 17.81 ± 0.01a*,b* | 20.14±0.65a*,b* | 13.06± 0.13a*,b** |
| Group IV | 16.45±0.06a*,b* | 19.45±0.73a*,b* | 12.47±0.12a*,b* |
| Group V | 17.45±0.77a*,b* | 19.08±0.18a*,b** | 12.02± 0.10a*,b* |
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non Significant; a →group I compared with groups II, III, IV, V; b →group II compared with groups III, IV, V; Details of group I-V are same as in Table 1.
Effect of flavone from and coumarin from on plasma lipoprotein in control and experimental rats
| Group I | 24.04±0.16b* | 30.06±0.41b* | 15.71±0.10b* |
| Group II | 17.17±0.22a* | 125.64±0.55a* | 24.36±0.17a* |
| Group III | 23.11±0.12a*,b* | 37.52± 0.37a*,b* | 16.80±0.20a*,b ** |
| Group IV | 25.27±0.19a*,b* | 31.58± 0.08a*,b* | 15.89±0.18 a**,b* |
| Group V | 24.51±0.26a*, b* | 32.37± 0.19a*,b* | 16.04±0.03a*,b* |
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non Significant; a →group I compared with groups II, III, IV, V; b →group II compared with groups III, IV, V; Details of group I-V are same as in Table 1.